Skip to main
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 37%
Buy 58%
Hold 5%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare is a company with a strong financial outlook, as evidenced by its positive earnings per share and strong EBITDA growth potential. Additionally, the company's focus on efficiency and sustainability measures is helping to improve its margin and drive benefits for the broader healthcare system. Despite recent caution in the market over hospital volume, Tenet's management expects to achieve its core growth targets and continue to generate significant free cash flow, which supports our positive outlook.

Bears say

Tenet Healthcare is facing challenges in both its USPI and Hospital/Other segments due to various factors such as weather impacts, vendor cyberattacks, and reductions in exchange volumes. While the company has been investing in acquisitions and new centers, it also faces risks such as reimbursement limitations and potential labor shortages. Furthermore, Tenet's high leverage and concentration in a few states increase its vulnerability to regional market and regulatory changes.

Tenet Healthcare (THC) has been analyzed by 19 analysts, with a consensus rating of Buy. 37% of analysts recommend a Strong Buy, 58% recommend Buy, 5% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 19 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $240.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $240.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.